Patient Centric Sampling and Quantitative Multiomics – Overcoming the Challenges for Routine Implementation
Hilton University of Florida Conference Center, Gainesville, Florida, USA – December 1-3, 2026.
Pairing multiomics with patient centric home sampling approaches has the potential to add an unparalleled dimension of convenience and accessibility to novel approaches for health monitoring and diagnostics. The PCSIG is convening leaders in this space for a workshop to explore the challenges and solutions to moving this approach from the experimental to the mainstream.
New sample types, new biomarkers, new assays, home sampling….. all will be explored in this collaborative setting!
Sponsors and Supporters
Thank-you to our Sponsors and Supporters for helping to make this event happen. If you are interested in sponsoring or supporting the event, please scroll down for more details.
Sponsors
Supporters
Mission
To define and address the barriers to the more widespread understanding of patient centric sampling for quantitative multiomics and its implementation for human healthcare and wellbeing.
Conference Overview
The term multiomics defines an integrated approach to biology that combines data from multiple “omes”, such a proteomics, metabolomics, genomics, lipidomics, to give a comprehensive view of biological systems. By analyzing these layers together, researchers can better understand complex molecular mechanisms, disease, and treatment responses. Measuring a wide range of biomarkers such as proteins, metabolites, lipids, oligonucleotides, etc, unlocks deeper insights to better understand human biology and contribute to our health and wellbeing. This combined multiomics approach has the possibility to move diagnostics beyond the clinic and into everyday life, helping not just those in treatment selection and monitoring, but engaging with the broader “healthy” population as well. Pairing multiomics with patient centric home sampling approaches adds the dimension of convenience and accessibility, opening up healthcare possibilities to existing underserved populations (remote communities, elderly, minorities, children, etc).
While the opportunity for more personalized, inclusive and proactive healthcare is clear, there are several challenges associated with routinely implementing these approaches:
- What patient populations are best served by this approach?
- How to actively engage with patients and include their voice in research
- How do we reliably quantitate these different types of molecule, in order to make considered clinical decisions? An important consideration for this, is how do we make these multiple measurements for different kinds of molecules work with the small sample volumes and alternative formats associated with patient centric samples?
- How does the sample logistics work to collect a high-quality sample and deliver it intact to the analytical laboratory, where it can be efficiently analysed and the data shared with the patient and their clinician?
Join us for this stand out PCSIG event, where we are bringing together experts to share their insights on the practical implementation of quantitative multiomics, particularly where samples are collected in a patient centric manner. By attending this event, you will learn about patient centric sampling for quantitative multiomics and actively contribute to facilitator-led discussions focussing on defining the challenges to its routine implementation for clinical care. We will then work together to prioritise these challenges and discuss how we can overcome them. Output from this event will include devising a plan for future activities to help bring this approach closer to routine implementation for patients, i.e. publications, webinars, conference presentations, working groups, etc.
Target Audience
The target audience for this event includes all those that are involved in the research and implementation of ‘omics approaches associated with human health and wellbeing. This includes patients, clinicians, clinical chemistry scientists, central laboratories, laboratory diagnostics providers, academics, pharmaceutical companies, contract research organisations, healthcare administrators, regulators, vendors of sampling technologies and analytical platforms, logistics providers and others that are interested in moving these approaches to the point where they can be routinely utilised.
The event is agnostic to the technologies and platforms used for all aspects of sample collection, processing, logistics, analytical approaches, data interpretation and delivery, etc.
Location Overview
Our event is located at the Hilton University of Florida, which is conveniently located on the University of Florida campus. The scientific events, catering, social events and accommodation are all located in this single location, facilitating an inclusive, collaborative atmosphere for this workshop-based event. The venue is also well placed for local attractions, domestic and international airport links.
Registration
Registration for the event is $500, which includes full registration for the event for a single delegate, including food service, but not including accommodation. Places are limited to 120, so please don’t delay in reserving your place.
Accommodation
The Hotel partner for this event is University of Florida Conference Center Gainesville, 1714 SW 34th Street, Gainesville, Florida, 32607, USA. Rooms for the event are available at $157 per night (including applicable state, local and occupancy taxes) using this link.
Travel
The event is located at the Hilton University of Florida Conference Center, Gainesville, Florida, which is on the Southwest Corner of the University of Florida on SW 34th Street. Follow this link for directions, airport information, etc.
Sponsorship
As a PCSIG sponsor, you’re in good company!
Get to know your fellow PCSIG Sponsors
Sponsorship of this event is available for $3,000. This includes
- Display table in the main meeting room.
- Full registration at the event for 2 delegates, both including food service, but not including accommodation.
- Your organisations name and logo featured on the event website and materials as appropriate. This will include a report on the PCSIG website, published after the event.
We also offer opportunities to separately sponsor lunches, dinner and the mixer event for $3,000. This sponsorship covers;
- Full registration for the event for 2 delegates, both including food service, but not including accommodation.
- Your organisations name and logo featured on the event website and materials as appropriate. This will include a report on the PCSIG website, published after the event. The event website will be temporarily hosted as a webpage on the PCSIG website leading up to the event.
- Your organisation associated with the chosen lunch, dinner, or mixer event.
If you have any questions, please contact neil@pcsig.org
Supporters
We also offer the opportunity to support the event for $1,000. This package includes;
- Full registration for the event for 1 delegate, including food service but not accommoadtion.
- Your organisations name and logo featured on the event website and materials as appropriate.
If you have any questions, please contact neil@pcsig.org
Scientific Program
December 1 2026
7:00 pm – Informal Reception in Conference Hotel Bar
December 2 2026
8:00 am – Registration & Breakfast
8:30 am – Welcome and introductory remarks
Tim Garrett – Associate Professor, University of Florida, USA
8:40 am – Opening Keynote – “From at-home testing to multi-omics: a tour du patient-centric sampling“
Erwin Berthier – CTO and Co-Founder, Tasso, Inc.
9:25 am – Plenary Speaker – “One Seat, Two Perspectives: Bridging the Patient-Scientist Divide“
Robyn Rourick – Senior Director, Bioanalytical Sciences, Genentech, USA
10:10 am – Break
Opportunity to visit vendor stands, mingle, reply to your e-mails, etc
10:45 am – Workshop 1; Following the Patient Journey for Patient Centric Sampling and Quantitative Multiomics – What are the Challenges to Routine Implementation?
Background to Roundtable Discussion Topic 1 – Adoption: The patient experience – Robyn Rourick (Genentech)
Background to Roundtable Discussion Topic 2 – Sample collection / transport – Speaker: Agnes Lenagh (PCSIG)
Background to Roundtable Discussion Topic 3 – Patient populations / indications – Speaker: Emily Harari (PCSIG)
Background to Roundtable Discussion Topic 4 – Assay and laboratory issues – Speaker: Erwin Berthier (Tasso, Inc)
11:15 pm – Workshop 1: Rotation 1
12:00 noon – Lunch
Opportunity to visit vendor stands, mingle, reply to your e-mails, etc
1:00 pm – Workshop 1: Rotation 2
1:30 pm – Workshop 1: Rotation 3
2:00 pm – Workshop 1: Rotation 4
2:30 pm – Break
Opportunity to visit vendor stands, mingle, reply to your e-mails, etc
3:00 pm – Feedback to Room from Workshop 1
Facilitators / notetakers feedback from each Workshop 1 topic discussion
5:30 pm – Mixer & Dinner
Opportunity to visit vendor stands, mingle, reply to your e-mails, etc
7:00 pm – Panel Session
Prioritization of challenges to address with solutions at Workshop 2
9:00 pm – Close Day 1
December 3 2026
8:00 am – Breakfast
8:30 am – Summary of Day 1
8:40 am – Workshop 2 – Solutions
Separate breakout table discussion for each “challenge to solution” defined in day 1
10:10 am – Feedback to Room from Workshop 2
10:30 am – Break
Opportunity to visit vendor stands, mingle, reply to your e-mails, etc
11:00 am – Agree Action Plan
11:30 am – Closing Keynote – “Innovations in Home Plasma Sampling and Quantitative Metabolomics for Precision Medicine“
David Wishart, Distinguished Professor, University of Alberta, Canada
11:55 am – Closing Remarks
Agreement on next steps / future activities and who will take responsibility.
12:00 noon – Meeting Ends
Speakers
Erwin Berthier, CTO and Co-Founder, Tasso, Inc.
Dr. Erwin Berthier is the Co-Founder and CTO of Tasso. An adept innovator, the technologies developed under his leadership at Tasso are empowering patients and clinicians to realize virtual care, perform frequent monitoring, and improve health outcomes. In addition to his role at Tasso, Erwin is also an Affiliate Assistant Professor in the Department of Chemistry at the University of Washington in Seattle.
Erwin received a Diplôme Ingénieur in Fluid Mechanics from ENSTA (Ecole Nationale Supérieure des Technologies Avancées) in Paris, an MS in Electrical Engineering from the University of Canterbury in New Zealand, and a PhD in Biomedical Engineering from the University of Wisconsin-Madison. He is the author of over 50 publications in peer-reviewed scientific journals and a co-author of the book “Open Microfluidics”.
Robyn Rourick, Senior Director, Bioanalytical Sciences, Genentech, USA
Robyn A. Rourick is Senior Director of Bioanalytical Sciences at Genentech, where she leads global bioanalytical assay outsourcing strategies supporting PK, ADA, and soluble biomarker programs across non-clinical and clinical development.
With 20+ years of biopharmaceutical leadership, Robyn’s career spans analytical innovation, pharmaceutical development, and operational strategy across the drug discovery-to-drug development continuum. She previously served as Senior Scientific Manager of Nonclinical Study Operations at Genentech, optimizing cross-functional execution and process efficiency for pre- and post-IND programs. Her extensive industry background includes roles as Director of Pharmaceutical Sciences at Kalypsys, Associate Director at DuPont Pharmaceuticals Research Labs, Group Leader of Analytical Technologies at CombiChem, and a decade at Bristol-Myers Squibb, where she pioneered the integration of advanced analytical technologies across discovery and development workflows including LC/MS and HT ADME screening.
Beyond her corporate leadership, Robyn actively shapes industry standards as a Board Member of the Pharmaceutical & BioScience Society (PBSS) and Chair of the San Diego Chapter. A dedicated advocate for patient-centric science, she collaborates with the Patient Centric Sampling Interest Group (PCSIG) and champions integrating the patient’s voice into analytical strategy and clinical trial design—advancing accessible, patient-focused approaches as her north star.
Robyn holds a B.S. in Chemistry from Fairfield University and an M.S. in Forensic Chemistry from the University of New Haven, completed under the mentorship of Dr. Henry Lee.
David Wishart, Distinguished Professor, University of Alberta, Canada
David Wishart earned his PhD in Molecular Biophysics from Yale University in 1991 and joined the University of Alberta as an assistant professor in 1995, becoming a full professor in 2003. He is currently a Distinguished University Professor in the Departments of Biological Sciences and Computing Science, with adjunct appointments in the Faculty of Pharmacy and Pharmaceutical Sciences and the Department of Laboratory Medicine and Pathology. He holds a Tier 1 Canada Research Chair in Metabolomics and Precision Medicine.
Wishart’s multidisciplinary research spans metabolomics, exposomics, precision medicine, precision nutrition, bioinformatics, cheminformatics, structural biology, artificial intelligence, robotics and analytical chemistry. His work has enabled the identification and quantification of metabolites in complex biological samples, the discovery of biomarkers for cancer, cardiovascular disease, neurological disorders, infectious disease, organ dysfunction and environmental exposure, and the development of computational tools for predicting molecular structures, properties, spectra, metabolic pathways and biological activities. After pioneering computational approaches for interpreting NMR spectra of biofluids in 1999, Wishart helped establish metabolomics as a major scientific discipline. In 2005, he launched the Human Metabolome Project and subsequently created the Human Metabolome Database. His laboratory has developed more than 100 freely accessible databases and software tools, including HMDB, DrugBank, FooDB, MetaboAnalyst, CFM-ID, BioTransformer, PathBank and NP-MRD, which are used by millions of researchers worldwide. In 2011, he co-founded The Metabolomics Innovation Centre (TMIC), Canada’s national metabolomics laboratory, which now includes eight research nodes, employs more than 30 scientists and houses over $35 million in equipment. He has also helped launch more than a dozen biotechnology companies, including BioTools, Chenomx and Molecular You. Wishart has authored or co-authored nearly 700 publications, received more than 166,000 citations and attained an h-index of 155. His honours include election to the Royal Society of Canada in 2017, appointment as Distinguished University Professor in 2018, the J. Gordin Kaplan Award in 2023, the NSERC Brockhouse Prize in 2024, the University Cup and NSERC Herzberg Gold Medal in 2025, and a Governor General’s Innovation Award in 2026.
Optional Off-Site Activities
December 1 (Before the Conference)
Meet at the Florida Museum of Natural History to explore exhibits and connect with colleagues before the conference begins.
Enjoy lunch on your own or with other attendees at a nearby restaurant.
Gather near the University of Florida Bat Houses to watch the evening emergence of thousands of bats at sunset.
Reconvene for dinner with the PCSIG group.
December 3 (After the Conference)
Join an informal afternoon hike along the La Chua Trail, known for its wildlife viewing opportunities and scenic prairie overlooks.
Location and time to be determined.
Participants may join any activity for all or part of the scheduled time. Activities are weather-dependent and subject to change.
Organizers
This event is brought to you by the following team, representing PCSIG
- Don Chace – Principal Scientist Mass Spectrometry Applications, Capitainer, USA
- Tim Garrett – Associate Professor, University of Florida, USA
- Emily Harari – Board Member, PCSIG, USA
- Agnes Lenagh – Board Member, PCSIG, USA; Director of Strategic Partnerships, University of Nebraska Medical Center, USA
- Neil Spooner – Chair, PCSIG, UK
- Jeremiah Tipton – Director and Applications Manager, Applied Omics & Life Sciences